Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 11:38 PM
Study NCT ID:
NCT03596294
Status:
COMPLETED
Last Update Posted:
2018-10-23
First Post:
2018-07-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan
Sponsor:
Idorsia Pharmaceuticals Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-05
First Submit QC Date:
None
Study First Post Date:
2018-07-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-22
Last Update Post Date:
2018-10-23
Last Update Post Date Type:
ACTUAL